• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.39 Up 0.22(2.69%) Mar 27, 4:00PM EDT
    |After Hours : 8.38 Down 0.01 (0.12%) Mar 27, 6:40PM EDT
    Add to Portfolio
    Prev Close:8.17
    Open:8.24
    Bid:8.31 x 200
    Ask:8.36 x 5800
    1y Target Est:8.35
    Beta:1.22
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.16 - 8.45
    52wk Range:4.90 - 9.19
    Volume:4,653,544
    Avg Vol (3m):6,152,580
    Market Cap:1.57B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 2.69%1.57B
    NVSUp 0.84%240.82B
    PFEUp 1.08%211.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.04
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback